Highnoon Laboratories Ltd
Shariah compliantAlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, HINOON's sales rose 5% to Rs 6.5bn, from Rs 6.2bn, and profit after tax fell 6% to Rs 735.1mn, from Rs 780.8mn (compared with Apr–Jun 2025).
Earnings per share were Rs 13.87, against Rs 14.74 a year earlier.
At Rs 924.79, HINOON trades at 12.1 times earnings, with a dividend yield of 5.1%.
- P/E ratio
- 12.1
- Dividend yield
- 5.1%
- Dividend payout
- 0%
- of earnings
- Return on equity
- 32%
- Net margin
- 15.0%
- trailing twelve months
- Debt to equity
- 0.08
HINOON quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 6.5bn | Rs 735.1mn | 11.4% | Rs 13.87 | — |
| Jan–Mar 2026 | Rs 7.5bn | Rs 1.0bn | 13.9% | Rs 19.78 | Rs 50.00 |
| Oct–Dec 2025 | Rs 7.4bn | Rs 1.4bn | 19.6% | Rs 27.32 | Rs 50.00 |
| Jul–Sep 2025 | Rs 7.1bn | Rs 945.2mn | 13.3% | Rs 17.84 | — |
| Apr–Jun 2025 | Rs 6.2bn | Rs 780.8mn | 12.7% | Rs 14.74 | — |
| Jan–Mar 2025 | Rs 7.0bn | Rs 954.6mn | 13.6% | Rs 18.02 | — |
| Oct–Dec 2024 | Rs 6.3bn | Rs 968.5mn | 15.3% | Rs 18.27 | Rs 40.00 |
| Jul–Sep 2024 | Rs 6.3bn | Rs 789.2mn | 12.6% | Rs 14.90 | — |
HINOON annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Dec 2025 | Rs 27.7bn | Rs 4.1bn | Rs 77.92 | Rs 50.00 |
| Year to Dec 2024 | Rs 24.6bn | Rs 3.4bn | Rs 63.95 | Rs 40.00 |
| Year to Dec 2023 | Rs 19.4bn | Rs 2.4bn | Rs 45.35 | Rs 30.00 |
| Year to Dec 2022 | Rs 15.8bn | Rs 2.4bn | Rs 45.62 | Rs 15.81 |
| Year to Dec 2021 | Rs 13.0bn | Rs 1.8bn | Rs 34.12 | Rs 14.37 |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 18.4bn
- Shareholders' equity
- Rs 12.9bn
- Cash & bank
- Rs 673.4mn
- Total debt
- Rs 1.1bn
- Current ratio
- 2.99
- 3-month high
- Rs 1060.42
- 3-month low
- Rs 905.20
- 1-month change
- -0.6%
- 3-month change
- -11.9%
Read more about HINOON
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 927.73P/E 11.1
- AGPAGP LtdRs 157.87P/E 12.7
- BFBIOBF Biosciences LtdRs 127.51P/E 20.0
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- FEROZFerozsons Laboratories LtdRs 325.07P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HALEONHaleon Pakistan LtdRs 680.74P/E 12.7
- HPLHoehcst Pakistan LtdRs 3905.85P/E 10.4
- IBLHLIBL HealthCare LtdRs 42.52P/E 19.1
- LIVENLiven Pharma LimitedRs 31.14
- MACTERMacter International LtdRs 259.64P/E 15.3
- OTSUOtsuka Pakistan LtdRs 366.30P/E 14.4
HINOON: common questions
What is HINOON's share price?
Highnoon Laboratories Ltd (HINOON) last closed at Rs 924.79 on the Pakistan Stock Exchange.
Does HINOON pay a dividend?
Yes. Highnoon Laboratories Ltd paid Rs 50.00 per share for the year to Dec 2025, and the stock's dividend yield is 5.1%.
What were HINOON's latest results?
In the Apr–Jun 2026 quarter, HINOON's sales rose 5% to Rs 6.5bn, from Rs 6.2bn, and profit after tax fell 6% to Rs 735.1mn, from Rs 780.8mn (compared with Apr–Jun 2025).
What is HINOON's P/E ratio?
At Rs 924.79, HINOON trades at 12.1 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.